Advances in the understanding of brain development, as well as the role that genes and environment play in addiction, are the focus of a review article published today in The American Journal of Psychiatry. The authors discuss how more than three decades of research in genetics and neuroscience can help investigators identify new evidence-based prevention strategies and effective treatments for opioid, alcohol and tobacco use disorders. The lead author is Dr. Nora Volkow, director of the National Institute on Drug Abuse, part of the National Institutes of Health.
- Maternal binge drinking linked to mood problems and alcohol abuse in offspring
- FDA Announces Major Crackdown on Vaping Sales to Teenagers